Optimizing the Clinical Application of CAR T-Cell Therapy: Best Practices for the Community Setting

Review key strategies for integrating CAR T-cell therapy into community-based management of hematologic malignancies with an on-demand Webcast FAQ module and downloadable slides from a live expert-led series.

Share

Program Content

Activities

FAQ: CAR T-Cell Therapy
Expert Guidance Frequently Asked Questions About CAR T-Cell Therapy in the Community Setting
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: February 25, 2020

Expires: December 19, 2022

Activities

CAR T-Cell Therapy
CAR T-Cell Therapy: Best Practices for Community Providers
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: September 06, 2019

Expires: September 04, 2020

Activities

CAR T-Cell Therapy
Community Oncology Best Practices in CAR T-Cell Therapy
Case Challenge
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: March 04, 2020

Expires: March 03, 2021

Faculty

cover img faculity

Michael R. Bishop, MD

Professor of Medicine, Director
Section of Hematology/Oncology,
Cellular Therapy Program
University of Chicago
Chicago, Illinois

cover img faculity

Jae H. Park, MD

Associate Member
Leukemia Service and Cellular Therapeutics Center
Memorial Sloan Kettering Cancer Center
New York, New York

cover img faculity

Joshua Sasine, MD, PhD

Assistant Professor of Medicine
Co-Director,
CAR T Program
Division of Hematology and Cellular Therapy
Cedars-Sinai Medical Center
Los Angeles, California

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Celgene

Gilead Sciences, Inc.

Kite A GILEAD Company